T 0686/10 (Use of creatine and cyclocreatine for the treatment of Huntington's disease and Parkinson's disease/ AVICENA) of 27.02.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T068610.20140227
- Date of decision
- 27 February 2014
- Case number
- T 0686/10
- Online on
- 31 March 2014
- Petition for review of
- -
- Application number
- 95939858.7
- IPC class
- A61K 31/675A61K 31/195A61K 31/66
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- USE OF CREATINE OR CREATINE ANALOGS FOR THE TREATMENT OF HUNTINGTON'S DISEASE, PARKINSON'S DISEASE AND AMYOTROPHIC LATERAL SCLEROSIS
- Applicant name
- Avicena Group, Inc.
THE GENERAL HOSPITAL CORPORATION - Opponent name
- Numico Research B.V.
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123European Patent Convention Art 83European Patent Convention Art 54(2)European Patent Convention Art 111(1)
- Keywords
- New main request at appeal proceedings
Remittal - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance for further prosecution on the basis of the main request.
3. The request for overturning the opposition division's decision on apportionment of costs is refused.